Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-053769
Filing Date
2012-10-04
Accepted
2012-10-04 18:16:42
Documents
2
Period of Report
2012-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd357117.html 3  
1 FORM 3 rrd357117.xml 3 3423
2 POWER OF ATTORNEY rrd320513_362969.htm EX-24. 3980
  Complete submission text file 0001181431-12-053769.txt   8979
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Reporting) CIK: 0000874015 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35670 | Film No.: 121130509
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3545 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SAN DIEGO CA 92121 888-734-8587
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations